Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function

Journal of Leukocyte Biology

Volumn 100, Issue 6, 2016, Pages 1273-1284

  Nam, Sorim ^a   Kang, Kyeongah ^a   Cha, Jae Seon ^a   Kim, Jung Woo ^b   Lee, Hee Gu ^c   Kim, Yonghwan ^a   Yang, Young ^a   Lee, Myeong Sok ^a   Lim, Jong Seok ^a  

^a Sookmyung Women's University   (South Korea)

^b PaiChai University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Myeloid cell; T cell proliferation; Tumor cell conditioned medium

Indexed keywords

INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 4; MESSENGER RNA; SIMVASTATIN; SMALL INTERFERING RNA; IL10 PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; INTERLEUKIN 10; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIVISION; EXPERIMENTAL MAMMARY NEOPLASM; EXPERIMENTAL MELANOMA; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; MYELOID-DERIVED SUPPRESSOR CELL; MYELOPOIESIS; PHYSIOLOGY; RNA INTERFERENCE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; INTERFERON REGULATORY FACTORS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID-DERIVED SUPPRESSOR CELLS; MYELOPOIESIS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIMVASTATIN; T-LYMPHOCYTE SUBSETS; TUMOR MICROENVIRONMENT;

EID: 85002883803     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1A0215-068RR     Document Type: Article

References (61)

1. Nagaraj, S., Gabrilovich, D. I. (2007) Myeloid-derived suppressor cells. Adv. Exp. Med. Biol. 601, 213–223.
2. Umansky, V., Sevko, A. (2013) Tumor microenvironment and myeloidderived suppressor cells. Cancer Microenviron. 6, 169–177.
3. Serafini, P. (2013) Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly. Immunol. Res. 57, 172–184.
4. +T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162, 5728–5737.
5. Huang, Y., Chen, X., Dikov, M. M., Novitskiy, S. V., Mosse, C. A., Yang, L., Carbone, D. P. (2007) Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. Blood 110, 624–631.
6. Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., Ostrand- Rosenberg, S. (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67, 10019–10026.
7. Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., Srikrishna, G. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181, 4666–4675.
8. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233–4244.
9. Rodríguez, P. C., Ochoa, A. C. (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222, 180–191
10. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791–5802.
11. Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B., Ochoa, A. C. (2002) Regulation of T cell receptor CD3 chain expression by L-arginine. J. Biol. Chem. 277, 21123–21129.
12. Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., Ozawa, K. (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109, 228–234.
13. Harari, O., Liao, J. K. (2004) Inhibition of MHC II gene transcription by nitric oxide and antioxidants. Curr. Pharm. Des. 10, 893–898.
14. Vig, M., Srivastava, S., Kandpal, U., Sade, H., Lewis, V., Sarin, A., George, A., Bal, V., Durdik, J. M., Rath, S. (2004) Inducible nitric oxide synthase in T cells regulates T cell death and immune memory. J. Clin. Invest. 113, 1734–1742.
15. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162–174.
16. Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., Saito, T. (1996) Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 z chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. U. S. A. 93, 13119–13124.
17. Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., Levi, B. Z. (1999) Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 163, 6468–6478.
18. Savitsky, D., Tamura, T., Yanai, H., Taniguchi, T. (2010) Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59, 489–510.
19. Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., Ozato, K. (2000) ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13, 155–165.
20. + dendritic cells. J. Exp. Med. 196, 1415–1425.
21. Cattoretti, G., Shaknovich, R., Smith, P. M., Jäck, H. M., Murty, V. V., Alobeid, B. (2006) Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J. Immunol. 177, 6930–6939.
22. Sasaki, H., Kurotaki, D., Osato, N., Sato, H., Sasaki, I., Koizumi, S., Wang, H., Kaneda, C., Nishiyama, A., Kaisho, T., Aburatani, H., Morse, H. C., Ozato, K., Tamura, T. (2015) Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells. Blood 125, 358–369.
23. Tamura, T., Yanai, H., Savitsky, D., Taniguchi, T. (2008) The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535–584.
24. Lu, R., Medina, K. L., Lancki, D. W., Singh, H. (2003) IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17, 1703–1708.
25. Huber, M., Lohoff, M. (2014) IRF4 at the crossroads of effector T-cell fate decision. Eur. J. Immunol. 44, 1886–1895.
26. Akbari, M., Honma, K., Kimura, D., Miyakoda, M., Kimura, K., Matsuyama, T., Yui, K. (2014) IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major. J. Immunol. 192, 2271–2279.
27. - dendritic cell development. Proc. Natl. Acad. Sci. USA 101, 8981–8986.
28. Tamura, T., Tailor, P., Yamaoka, K., Kong, H. J., Tsujimura, H., O’Shea, J. J., Singh, H., Ozato, K. (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174, 2573–2581.
29. Yamamoto, M., Kato, T., Hotta, C., Nishiyama, A., Kurotaki, D., Yoshinari, M., Takami, M., Ichino, M., Nakazawa, M., Matsuyama, T., Kamijo, R., Kitagawa, S., Ozato, K., Tamura, T. (2011) Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One 6, e25812.
30. Grumont, R. J., Gerondakis, S. (2000) Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferonregulated gene expression by rel/nuclear factor kB. J. Exp. Med. 191, 1281–1292.
31. Gupta, S., Jiang, M., Anthony, A., Pernis, A. B. (1999) Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 190, 1837–1848.
32. Rehli, M., Sulzbacher, S., Pape, S., Ravasi, T., Wells, C. A., Heinz, S., Söllner, L., El Chartouni, C., Krause, S. W., Steingrimsson, E., Hume, D. A., Andreesen, R. (2005) Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J. Immunol. 174, 7111–7122.
33. El Chartouni, C., Schwarzfischer, L., Rehli, M. (2010) Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology 215, 821–825.
34. Fields, R. C., Osterholzer, J. J., Fuller, J. A., Thomas, E. K., Geraghty, P. J., Mul é, J. J. (1998) Comparative analysis of murine dendritic cells derived from spleen and bone marrow. J. Immunother. 21, 323–339.
35. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123–1131.
36. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., Ostrand-Rosenberg, S. (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179, 977–983.
37. Honma, K., Udono, H., Kohno, T., Yamamoto, K., Ogawa, A., Takemori, T., Kumatori, A., Suzuki, S., Matsuyama, T., Yui, K. (2005) Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. Proc. Natl. Acad. Sci. USA 102, 16001–16006.
38. + T cells derived from patients with multiple sclerosis. J. Immunol. 187, 3431–3437.
39. Nakashima, Y., Haneji, T. (2013) Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss. PLoS One 8, e72033.
40. So, A. Y., Sookram, R., Chaudhuri, A. A., Minisandram, A., Cheng, D., Xie, C., Lim, E. L., Flores, Y. G., Jiang, S., Kim, J. T., Keown, C., Ramakrishnan, P., Baltimore, D. (2014) Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. Blood 124, 1502–1512.
41. + cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6, 409–421.
42. Mauti, L. A., Le Bitoux, M. A., Baumer, K., Stehle, J. C., Golshayan, D., Provero, P., Stamenkovic, I. (2011) Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J. Clin. Invest. 121, 2794–2807.
43. Jiang, J., Guo, W., Liang, X. (2014) Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients. Hum. Immunol. 75, 1128–1137.
44. Zhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., Akashi, K., Tenen, D. G. (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21, 853–863.
45. Iwasaki, H., Somoza, C., Shigematsu, H., Duprez, E. A., Iwasaki-Arai, J., Mizuno, S., Arinobu, Y., Geary, K., Zhang, P., Dayaram, T., Fenyus, M. L., Elf, S., Chan, S., Kastner, P., Huettner, C. S., Murray, R., Tenen, D. G., Akashi, K. (2005) Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600.
46. Ito, T., Nishiyama, C., Nakano, N., Nishiyama, M., Usui, Y., Takeda, K., Kanada, S., Fukuyama, K., Akiba, H., Tokura, T., Hara, M., Tsuboi, R., Ogawa, H., Okumura, K. (2009) Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-g. Int. Immunol. 21, 803–816.
47. Waight, J. D., Netherby, C., Hensen, M. L., Miller, A., Hu, Q., Liu, S., Bogner, P. N., Farren, M. R., Lee, K. P., Liu, K., Abrams, S. I. (2013) Myeloid-derived suppressor cell development is regulated by a STAT/ IRF-8 axis. J. Clin. Invest. 123, 4464–4478.
48. Kanno, Y., Levi, B. Z., Tamura, T., Ozato, K. (2005) Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J. Interferon Cytokine Res. 25, 770–779.
49. Schmidt, M., Hochhaus, A., König-Merediz, S. A., Brendel, C., Proba, J., Hoppe, G. J., Wittig, B., Ehninger, G., Hehlmann, R., Neubauer, A. (2000) Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. J. Clin. Oncol. 18, 3331–3338.
50. Jo, S. H., Schatz, J. H., Acquaviva, J., Singh, H., Ren, R. (2010) Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood 116, 2759–2767.
51. Valdez, P. A., Vithayathil, P. J., Janelsins, B. M., Shaffer, A. L., Williamson, P. R., Datta, S. K. (2012) Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 36, 668–679.
52. Sinha, P., Clements, V. K., Fulton, A. M., Ostrand-Rosenberg, S. (2007) Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 67, 4507–4513.
53. Lohoff, M., Mak, T. W. (2005) Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 5, 125–135.
54. Wills-Karp, M., Finkelman, F. D. (2008) Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci. Signal. 1, p e55.
55. Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., Colombo, M. P., Zanovello, P. (2003) IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170, 270–278.
56. Munera, V., Popovic, P. J., Bryk, J., Pribis, J., Caba, D., Matta, B. M., Zenati, M., Ochoa, J. B. (2010) Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 251, 120–126.
57. Jiang, J., Wang, Z., Li, Z., Zhang, J., Wang, C., Xu, X., Qin, Z. (2010) Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression. Gene Ther. 17, 991–999.
58. Xiao, G., Wang, X., Sheng, J., Lu, S., Yu, X., Wu, J. D. (2015) Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype. J. Hematol. Oncol. 8, 13.
59. Kidiyoor, A., Schettini, J., Besmer, D. M., Rego, S. L., Nath, S., Curry, J. M., Roy, L. D., Dréau, D., Mukherjee, P. (2014) Pancreatic cancer cells isolated from Muc1-null tumors favor the generation of a mature less suppressive MDSC population. Front. Immunol. 5, 67.
60. Papaspyridonos, M., Matei, I., Huang, Y., do Rosario Andre, M., Brazier-Mitouart, H., Waite, J. C., Chan, A. S., Kalter, J., Ramos, I., Wu, Q., Williams, C., Wolchok, J. D., Chapman, P. B., Peinado, H., Anandasabapathy, N., Ocean, A. J., Kaplan, R. N., Greenfield, J. P., Bromberg, J., Skokos, D., Lyden, D. (2015) Id1 suppresses antitumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat. Commun. 6, 6840.
61. Paschall, A. V., Zhang, R., Qi, C. F., Bardhan, K., Peng, L., Lu, G., Yang, J., Merad, M., McGaha, T., Zhou, G., Mellor, A., Abrams, S. I., Morse, H. C., Ozato, K., Xiong, H., Liu, K. (2015) IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation. J. Immunol. 194, 2369–2379.